Momentum Stocks: Schlumberger Limited (SLB), Galena Biopharma, Inc. (GALE), Tenet Healthcare Corp. (THC)

Schlumberger Limited (SLB) retreated with the stock falling -0.51% or $-0.43 to close at $84.2 on light trading volume of 3.51M compared its three months average trading volume of 5.56M. The Houston Texas 77056 based company operating under the Oil & Gas Equipment & Services industry has been trending up for the last 52 weeks, with the shares price now 24.09% up for the period and up by 23.89% so far this year. With price target of $94.45 and a 44.99% rebound from 52-week low, Schlumberger Limited has plenty of upside potential, making it a hold with a view buy.

Schlumberger Limited supplies technology, integrated project management, and information solutions to the oil and gas exploration and production industry worldwide. Its Reservoir Characterization Group segment provides reservoir imaging, monitoring, and development services; wireline technologies for open and cased-hole services; exploration and production pressure and flow-rate measurement services comprising surface and downhole services; software integrated solutions, such as software, consulting, information management, and IT infrastructure services; consulting services for reservoir characterization, field development planning, and production enhancement; and petrotechnical data services and training solutions, as well as integrated management services. Its Drilling Group segment designs, manufactures, and markets roller cone and fixed cutter drill bits; supplies drilling fluid systems; provides pressure drilling and underbalanced drilling solutions, and environmental services and products; mud logging services; land drilling rigs and related support services; and well planning and drilling, engineering, supervision, logistics, procurement, contracting, and drilling rig management services, as well as bottom-hole-assembly, borehole-enlargement technologies, impact tools, tubulars, and tubular services. Its Production Group segment provides well services comprising pressure pumping, well cementing, stimulation, and intervention services; well completion services and equipment that include packers, safety valves, and sand control technology, as well as completions technology and equipment; artificial lifts; coiled tubing equipment and services, and slickline services; development, management, and environmental protection services for water resources; and integrated production and production management services. The company was formerly known as Socie´te´ de Prospection E´lectrique. Schlumberger Limited was founded in 1926 and is based in Houston, Texas.

Galena Biopharma, Inc. (GALE) had a active trading with around 3.48M shares changing hands compared to its three month average trading volume of 2.2M. The stock traded between $2.03 and $2.35 before closing at the price of $2.05 with -13.87% change on the day. The San Ramon California 94583 based company is currently trading 11.41% above its 52 week low of $1.84 and -95.88% below its 52 week high of $49.8. Both the RSI indicator and target price of  and $7.67 respectively, lead us to believe that it could rise over the coming weeks.

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs. The company’s lead product candidate, NeuVax (nelipepimut-S), is in Phase III clinical trials for the prevention of recurrence in early- stage and node-positive breast cancer with low to intermediate human epidermal growth factor receptor (HER2) expression; Phase IIb clinical trials in combination with Herceptin for HER2 1+/2+ node-positive and high-risk node-negative breast cancer treatment; and Phase II clinical trials in combination with trastuzumab for node positive and negative HER2 IHC 3+ patients. It also develops GALE-301 (folate binding protein), which is in Phase IIa clinical trials for the prevention of recurrence in patients with ovarian and endometrial cancers; GALE-302, a version of the E39 peptide that is in Phase 1b clinical trial for investigating a novel vaccination series; and GALE-401 (anagrelide controlled release), which is in a Phase II clinical trial for the treatment of patients with myeloproliferative neoplasms to lower elevated platelet levels. Galena Biopharma, Inc. has strategic development and commercialization partnership with Dr. Reddy’s Laboratories Ltd. for NeuVax in breast and gastric cancers. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Galena Biopharma, Inc. in September 2011. Galena Biopharma, Inc. was founded in 2003 and is based in San Ramon, California.

Tenet Healthcare Corp. (THC) saw its value increase by 1.97% as the stock gained $0.29 to finish the day at a closing price of $15. The stock was higher in trading and has fluctuated between $14.06-$34.08 per share for the past year. The shares, which traded within a range of $14.57 to $15.23 during the day, are down by -31.82% in the past three months and down by -45.73% over the past six months. It is currently trading -0.13% below its 20 day moving average and -12.91% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $26.94 a share over the next twelve months. The current relative strength index (RSI) reading is 42.98.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Tenet Healthcare Corp., together with its subsidiaries, primarily operates acute care hospitals and related healthcare facilities. The company operates through three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive, critical, and coronary care units; physical therapy, orthopedic, oncology, and outpatient services; tertiary care services, including open-heart surgery, neonatal intensive care, and neurosciences; quaternary care services for heart, liver, kidney, and bone marrow transplants; quaternary pediatric and burn services; gamma-knife brain surgery; and cyberknife radiation therapy for tumors and lesions in the brain, lung, neck, and spine. In addition, it offers clinical research programs related to cardiovascular and pulmonary diseases, musculoskeletal disorders, neurological disorders, genitourinary diseases, and various cancers, as well as drug and medical device studies. Further, the company operates freestanding ambulatory surgery and imaging centers, short-stay surgical facilities, and Aspen’s hospitals and clinics. Additionally, it offers operational management for patient access, accounts receivable management, health information management, revenue integrity, and patient financial services; communications and engagement solutions; and clinical integration, financial risk management, and population health management services. As of December 31, 2015, the company operated 86 hospitals, 20 short-stay surgical hospitals, and approximately 475 outpatient centers; and 9 private hospitals and clinics, as well as 249 ambulatory surgery, 20 imaging, and 35 urgent care centers in the United Kingdom. Tenet Healthcare Corp. was founded in 1967 and is headquartered in Dallas, Texas.

CHRIS BUTLER2 days ago

Source: http://istreetwire.com/2016/12/30/momentum-stocks-schlumberger-limited-slb-galena-biopharma-inc-gale-tenet-healthcare-corp-thc/

5 apps that automate your money and make you richer

Consumers now have more options to take small steps toward financial freedom

A plethora of digital money-tracking services have emerged in recent years to overtake the humble paper-and-pencil logs of the past, from budgeting apps like Mint and HelloWallet to expense apps like SplitWise. Today, such services are entering a new frontier: automation.

For many consumers — especially millennials — starting a savings plan from scratch can feel overwhelming — but with these new automated tools, you can start saving without thinking about it. Consumers now have a wealth of options to choose from to take small steps toward financial freedom. Here are five.

Digit

Digit is a kind of digital change jar for money saving. The free app connects with a user’s checking account and analyzes spending habits, taking out a small amount of money (usually between $5 and $50) every few days when its algorithms determine it can be spared. The money is then moved to a Federal Deposit Insurance Corp.-insured Digit savings account, and can be transferred at any time to a checking account within one business day.

Digit

The app differs from popular saving and budgeting services like Mint in that it doesn’t run on a home page with an overview of spending habits, instead relying on an SMS-based chatbot that users can text directly for information, including recent activity like checking balance, recent transactions, and how much money has been saved. There is a Digit dashboard with an overview of account activity, but the majority of activity through Digit occurs by text or in its in-app messaging service. The app makes saving money seamless, but works best for users with a steady income.

Previously, as a freelancer, the service proved frustrating for me — I often spent little money while I scraped by until the next paycheck, only to find Digit’s algorithms determined that I had cash to spare and withdrew more from my account. There is a feature that allows users to pause saving for a set amount of time when money is tight, but I felt that took away from the top advertised benefit of the app, which is 

Qapital

Similar to Digit, Qapital puts small chunks of change into a savings account for users, but unlike Digit, it lets you set the rules. Just sync the app with your bank account and credit cards and input a goal to save up to, like a vacation or paying off debt. Customize the plan by deciding what actions and daily habits trigger a deposit. (When Qapital sets your savings aside, it takes it from you bank account, and not your credit card.)

Users can round up extra change ($0.30 from that $2.70 coffee you bought this morning, for example), set a fixed daily or weekly amount to save, or connect the app with Apple Health to reward themselves for fitness goals. Set a weekly budget for something like Starbucks SBUX, -0.07%   or Amazon AMZN, -1.51%   purchases and let the app deposit the difference into savings if you spend less than anticipated.

Qapital

Qapital aims to make saving more fun. It could deposit money in your savings account whenever you do something with your phone like upload an Instagram photo or every time the international space station orbits over the U.S., or you can add money to the savings account each time you save a track to Spotify playlists. With a “freelancer rule” that saves 30% of every deposit for tax day, this app is the clear money-saving choice for anyone who doesn't have a steady paycheck. Qapital is free to download and use, and makes money through interest on savings it holds for users like a typical bank. The app rewards users for activities they already do, and makes saving fun in the process.

Acorns

Take your savings one step further by actually investing it. Acorns is an option for users who want to try their hand at investing in stocks and bonds but are hesitant to do so. It connects to any debit or credit card and rounds up change from each purchase to the dollar, investing it in one of five diversified portfolios developed in part by Nobel Prize-winning economist Harry Markowitz.

Users start by saving an average of $33 to $35 a month, or more than $400 a year in spare change, said Jennifer Barrett, the chief education officer at Acorns. “For someone really nervous about starting to invest this is a way to go in with minimal effort and minimal risk,” she said.

Acorns

Acorns also recently introduced a “Found Money” feature, through which companies it partners with — like HotelTonight and Blue Apron — reward users for shopping there with small contributions of around $10. The app is free to download but charges users $1 once a month after they begin investing. Users who accrue more than $5,000 in an account will pay 0.25% a year instead of $1 a month. Still, $1 a month can add up for consumers, particularly if the account is small to begin with. So if you truly are just investing spare change, Acorns may not be right for you.